Stocktoria
ALIGN TECHNOLOGY INC ALGN
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2001-01-26 · LEI
ALIGN TECHNOLOGY INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B | $4.0B | $3.9B | $3.7B | $4.0B | $2.5B | $2.4B | $2.0B | $1.5B | $1.1B |
| Gross profit | $2.7B | $2.8B | $2.7B | $2.6B | $2.9B | $1.8B | $1.7B | $1.4B | $1.1B | $815.3M |
| R&D expense | $369.9M | $364.2M | $346.8M | $305.3M | $250.3M | $175.3M | $157.4M | $128.9M | $97.6M | $75.7M |
| SG&A expense | $1.8B | $1.8B | $1.7B | $1.7B | $1.7B | $1.2B | $1.1B | $852.4M | — | — |
| Operating income | $545.8M | $607.6M | $643.3M | $642.6M | $976.4M | $387.2M | $542.5M | $466.6M | $353.6M | $248.9M |
| Income tax | $174.9M | $187.6M | $196.2M | $237.5M | $240.4M | -$1.4B | $112.3M | $57.7M | $130.2M | $51.2M |
| Net income | $410.4M | $421.4M | $445.1M | $361.6M | $772.0M | $1.8B | $442.8M | $400.2M | $231.4M | $189.7M |
| EPS (diluted) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 |
| Operating cash flow | $593.2M | $738.2M | $785.8M | $568.7M | $1.2B | $662.2M | $747.3M | $554.7M | $438.5M | $247.7M |
| Free cash flow | $490.8M | $622.7M | $608.1M | $276.8M | $771.4M | $507.3M | $597.6M | $331.4M | $242.8M | $177.1M |
| Cash & equivalents | $1.1B | $1.0B | $937.4M | $942.0M | $1.1B | $960.8M | $550.4M | $636.9M | $449.5M | $389.3M |
| Inventory | $226.3M | $254.3M | $296.9M | $338.8M | $230.2M | $139.2M | $112.1M | $55.6M | $31.7M | $27.1M |
| Total assets | $6.2B | $6.2B | $6.1B | $5.9B | $5.9B | $4.8B | $2.5B | $2.1B | $1.8B | $1.4B |
| Total liabilities | $2.2B | $2.4B | $2.5B | $2.3B | $2.3B | $1.6B | $1.2B | $799.6M | $629.7M | $400.8M |
| Shareholders' equity | $4.0B | $3.9B | $3.6B | $3.6B | $3.6B | $3.2B | $1.3B | $1.3B | $1.2B | $999.3M |
Growth · year-over-year · Revenue CAGR 15.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +0.9% | +3.5% | +3.4% | -5.5% | +59.9% | +2.7% | +22.4% | +33.5% | +36.4% | +27.7% |
| Net income growth | -2.6% | -5.3% | +23.1% | -53.2% | -56.5% | +301.1% | +10.6% | +72.9% | +22.0% | +31.7% |
| EPS growth | +0.5% | -3.3% | +26.0% | -52.4% | -56.8% | +305.2% | +12.4% | +73.9% | +21.5% | +31.6% |
| Free cash flow growth | -21.2% | +2.4% | +119.6% | -64.1% | +52.1% | -15.1% | +80.3% | +36.5% | +37.1% | -4.0% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.